Statins, plasma cholesterol, and risk of Parkinson's disease: a prospective study.

@article{Huang2015StatinsPC,
  title={Statins, plasma cholesterol, and risk of Parkinson's disease: a prospective study.},
  author={Xuemei Huang and Alvaro Alonso and Xuguang Guo and David M. Umbach and Maya L Lichtenstein and Christie M. Ballantyne and Richard B. Mailman and Thomas H. Mosley and Honglei Chen},
  journal={Movement disorders : official journal of the Movement Disorder Society},
  year={2015},
  volume={30 4},
  pages={552-9}
}
Previous findings on the association of statins, plasma lipids, and Parkinson's disease (PD) are confounded by the fact that statins also affect lipid profiles. We prospectively examined plasma lipids and statin use in relation to PD in the Atherosclerosis Risk in Communities (ARIC) Study. Statin use and plasma lipids were assessed at baseline (visit 1, 1987-89) and at three triennial visits thereafter (visits 2-4) until 1998. Potential PD cases were identified from multiple sources and… CONTINUE READING